ACD will soon be releasing our 100^th cell-based protein tyrosine kinase assay and we invite you to share in the celebration! Our assay platform reveals kinase biologies that can go undetected using more traditional biochemical assays.

We want you to learn more about our system and invite you to participate in our upcoming webinar titled “Exploring the impact of genetically-altered kinases on small-molecule efficacy”.

This ongoing series is hosted by Carna Biosciences and the next presentation is scheduled for September 9^th at 10 am PDT. Registration is free and will entitle you to promotional discounts on our profiling services. Please visit http://www.carnabio.com/english/webinar/ to learn more and to register for the event.